Skip to main content
Clinical Trials/NCT03832166
NCT03832166
Completed
N/A

A Prospective, Randomized Two Group Study to Evaluate the Feasibility and Initial Efficacy of a Community-engaged Screening, Identification, and F&V Intervention to Improve F&V Intake and CKD Outcomes in 140 AA Adults

Baylor Research Institute1 site in 1 country142 target enrollmentJanuary 24, 2019
ConditionsCKDESRD

Overview

Phase
N/A
Intervention
Not specified
Conditions
CKD
Sponsor
Baylor Research Institute
Enrollment
142
Locations
1
Primary Endpoint
Change from baseline of Urine albumin-to-creatinine ratio (ACR) at 6 weeks and 6 months
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

To evaluate a scalable population health strategy to 1) screen, 2) identify, and 3) intervene with individuals at high risk of CKD progression to ESRD that could be implemented in other high risk communities and health care systems. This novel study will evaluate the feasibility and preliminary efficacy of providing F&V to individuals identified at high risk study for CKD and ESRD through community health screenings. Further, it will evaluate whether providing education as to how to prepare F&V for consumption, the latter being done for all F&V recipients in PI's preliminary published studies but its efficacy was not specifically tested, increases F&V intake and thereby reduces CKD progression risk as well as related clinical outcomes.

Detailed Description

"Fruits and Veggies for Health" is a prospective, randomized two group study to evaluate a community-engaged screening, identification, and F\&V intervention to improve CKD outcomes in 140 AA adults (greater than 18 years). Participants will be randomized to a 1) F\&V only (F\&V Only), or 2) F\&V plus a nutrition/cooking program (F\&V + Cook).

Registry
clinicaltrials.gov
Start Date
January 24, 2019
End Date
July 14, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Willingness to participate in 6 month F\&V study
  • Positive urine dipstick.
  • African American (self declared) race
  • Access to internet via personal computer or mobile device
  • Ability to read and write in English

Exclusion Criteria

  • Negative urine dipstick
  • Currently receiving dialysis or needing dialysis (stage 5 Kidney disease)
  • Have received or need kidney transplant
  • Pregnant or plan to become pregnant in the next 6 months
  • Baseline urine potassium \> 60 mEq/g creatinine
  • Nephrotic proteinuria demonstrated on urine ACR measurement
  • Lacking access to the internet via personal computer or mobile device
  • Unable to read or write in English

Outcomes

Primary Outcomes

Change from baseline of Urine albumin-to-creatinine ratio (ACR) at 6 weeks and 6 months

Time Frame: Baseline; 6 weeks; 6 months

Measure of renal damage

Changes from baseline in dietary fat intake at 6 weeks and 6 months

Time Frame: Baseline; 6 weeks; 6 months

Track changes in fat (g) intake via ASA24 food diary

Changes from baseline in caloric intake at 6 weeks and 6 months

Time Frame: Baseline; 6 weeks; 6 months

Track changes in total caloric(kcal) intake via ASA24 food diary

Changes from baseline in fruit and vegetable intake at 6 weeks and 6 months

Time Frame: Baseline; 6 weeks; 6 months

Track changes in fruit and vegetable intake via ASA24 food diary

Change from baseline concentration of Urine angiotensinogen (AGT) at 6 weeks and 6 months

Time Frame: Baseline; 6 weeks; 6 months

Primary surrogate marker of eGFR

Secondary Outcomes

  • Changes from baseline in systolic and diastolic Blood pressure at 6 weeks and 6 months(Baseline; 6 weeks; 6 months)
  • Changes from baseline in Body mass index (BMI) at 6 weeks and 6 months(Baseline; 6 weeks; 6 months)
  • Changes from baseline in Blood glucose at 6 weeks and 6 months(Baseline; 6 weeks; 6 months)
  • Changes from baseline in serum Lipoprotein levels at 6 weeks and 6 months(Baseline; 6 weeks; 6 months)
  • Changes from baseline in serum Glycosolated hemoglobin A1C (HgA1C) levels at 6 weeks and 6 months(Baseline; 6 weeks; 6 months)

Study Sites (1)

Loading locations...

Similar Trials